# TRAK1

## Overview
TRAK1 is a gene that encodes the trafficking kinesin protein 1, a critical adaptor protein involved in the intracellular transport of mitochondria. This protein is characterized by its coiled-coil domains, which facilitate interactions with motor proteins such as kinesin-1 and dynein-dynactin, enabling the bidirectional transport of mitochondria along microtubules (Aslan2023Trak; Henrichs2020Mitochondriaadaptor). TRAK1 plays a vital role in maintaining mitochondrial morphology and function, particularly within neurons, by promoting mitochondrial tethering and fusion (Lee2017Hypertonialinked). The protein's interactions with mitofusins and its ability to enhance kinesin-1 processivity are crucial for effective mitochondrial distribution, supporting synaptic function and overall cellular health (Henrichs2020Mitochondriaadaptor). Mutations in the TRAK1 gene are linked to severe neurological disorders, highlighting its clinical significance (BenZeev2017Deleterious).

## Structure
TRAK1 is a protein characterized by its coiled-coil domains, which are crucial for its function as an adaptor protein in mitochondrial transport. These domains facilitate interactions with motor proteins such as kinesin-1 and dynein-dynactin, enabling the bidirectional transport of mitochondria along microtubules (Aslan2023Trak; Henrichs2020Mitochondriaadaptor). The N-terminal region of TRAK1 includes a HAP1-N domain, while the C-terminal region contains a kinesin-binding Milton domain, which are essential for its role in mitochondrial axonal transport (Li2024Role).

TRAK1 contains specific motifs such as the CC1 box and the Spindly motif, which are important for activating dynein-dynactin motility (Canty2021TRAK; Aslan2023Trak). The Spindly motif is particularly significant for robust activation of dynein-dynactin (Canty2021TRAK). TRAK1 undergoes post-translational modifications, including phosphorylation, which can influence its interactions and function (Gladkova2024A).

The protein is subject to alternative splicing, resulting in multiple isoforms that contribute to its functional diversity (BenZeev2017Deleterious). These structural features and modifications enable TRAK1 to effectively mediate mitochondrial transport and distribution within cells.

## Function
TRAK1 (trafficking kinesin protein 1) plays a crucial role in mitochondrial transport within neurons, facilitating the movement of mitochondria along microtubules. It interacts with the motor protein kinesin-1, particularly the KIF5B subunit, to promote anterograde transport of mitochondria into axons, which is essential for neuronal polarization and axonal development (van2013TRAKMilton). TRAK1 also associates with the dynactin subunit p150Glued, part of the dynein motor complex, indicating its involvement in bidirectional transport (van2013TRAKMilton).

TRAK1 is essential for maintaining mitochondrial morphology and function by promoting mitochondrial tethering and fusion. It interacts with mitofusins Mfn1 and Mfn2 on the outer mitochondrial membrane, facilitating mitofusin-mediated mitochondrial fusion, which is crucial for maintaining mitochondrial morphology and function (Lee2017Hypertonialinked). TRAK1's role in mitochondrial fusion is vital for stress-induced mitochondrial hyperfusion, a cytoprotective process aiding cell survival under stress conditions (Lee2017Hypertonialinked).

In crowded cellular environments, TRAK1 enhances the processivity of kinesin-1, allowing it to navigate obstacles and maintain effective transport, which is crucial for neuronal health (Henrichs2020Mitochondriaadaptor). This function is particularly important in neurons, where efficient mitochondrial distribution supports synaptic function and overall cellular health (Henrichs2020Mitochondriaadaptor).

## Clinical Significance
Mutations in the TRAK1 gene are associated with several severe neurological disorders. Biallelic variants, including homozygous and compound heterozygous mutations, are linked to developmental and epileptic encephalopathy 68 (DEE68), an autosomal recessive disorder characterized by early-onset twitching, myoclonic jerks, and refractory generalized tonic-clonic seizures, often leading to early death. Clinical features also include developmental delays, axial hypotonia, spasticity, and clonus, with possible cortical atrophy observed in brain imaging (Li2024Role). 

Deleterious variants in TRAK1 disrupt mitochondrial movement, leading to fatal infantile encephalopathy. These variants result in premature termination during translation, producing truncated proteins that impair mitochondrial localization and motility. Patients with these mutations exhibit severe neurological symptoms, including polymyoclonus, generalized tonic-clonic seizures, and progressive spasticity, often resulting in rapid developmental regression and early mortality (BenZeev2017Deleterious).

Alterations in TRAK1 expression are also implicated in temporal lobe epilepsy (TLE). Decreased TRAK1 expression is observed in TLE patients and animal models, leading to increased mitochondrial fission and heightened seizure susceptibility. Overexpression of TRAK1 can mitigate these effects, suggesting its potential as a therapeutic target (Wu2020TRAK1Mediated).

## Interactions
TRAK1 interacts with several proteins to facilitate mitochondrial transport within cells. It binds to kinesin-1, particularly the KIF5B subunit, which is crucial for anterograde transport towards axons. This interaction does not require the kinesin light chain, indicating a unique binding mechanism (van2013TRAKMilton). TRAK1 also associates with the dynein/dynactin motor complex, specifically interacting with the p150Glued subunit, which is involved in dynein-mediated transport (van2013TRAKMilton).

TRAK1 forms complexes with Miro1, a mitochondrial Rho GTPase, to facilitate mitochondrial movement along microtubules. The N-terminal 532 residues of TRAK1 are sufficient to link kinesin and Miro1, forming kinesin-TRAK1-Miro1 (KTM) complexes that move along microtubules (Aslan2023Trak). TRAK1 can also tether mitochondria to microtubules, enhancing their transport capabilities when combined with KIF5BΔ (Henrichs2020Mitochondriaadaptor).

TRAK1's interaction with RhoT1 is essential for anterograde trafficking of mitochondria, which is crucial for avoiding oxidative stress in cells. This interaction negatively regulates the binding between RhoT1 and TRAK2, leading to increased anterograde trafficking of mitochondria (Onodera2018Arf6driven).


## References


[1. (Wu2020TRAK1Mediated) Hao Wu, Yong Liu, Huanfa Li, Changwang Du, Kuo Li, Shan Dong, Qiang Meng, and Hua Zhang. Trak1-mediated abnormality of mitochondrial fission increases seizure susceptibility in temporal lobe epilepsy. Molecular Neurobiology, 58(3):1237–1247, October 2020. URL: http://dx.doi.org/10.1007/s12035-020-02175-y, doi:10.1007/s12035-020-02175-y. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-020-02175-y)

[2. (Henrichs2020Mitochondriaadaptor) Verena Henrichs, Lenka Grycova, Cyril Barinka, Zuzana Nahacka, Jiri Neuzil, Stefan Diez, Jakub Rohlena, Marcus Braun, and Zdenek Lansky. Mitochondria-adaptor trak1 promotes kinesin-1 driven transport in crowded environments. Nature Communications, June 2020. URL: http://dx.doi.org/10.1038/s41467-020-16972-5, doi:10.1038/s41467-020-16972-5. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-16972-5)

[3. (BenZeev2017Deleterious) Bruria Ben-Zeev, Ortal Barel, May Christine Malicdan, Osama Atawa, Et Cohen Ganelin, Gali Heimer, Andreea Nissenkorn, Chen Hoffman, Judith Kandel, Michael Schrader, David M. Eckmann, and Yair Anikster. Deleterious variants in trak1 disrupt mitochondrial movement and cause fatal infantile encephalopathy. European Journal of Paediatric Neurology, 21:e49, June 2017. URL: http://dx.doi.org/10.1016/j.ejpn.2017.04.888, doi:10.1016/j.ejpn.2017.04.888. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejpn.2017.04.888)

[4. (Lee2017Hypertonialinked) Crystal A. Lee, Lih-Shen Chin, and Lian Li. Hypertonia-linked protein trak1 functions with mitofusins to promote mitochondrial tethering and fusion. Protein &amp; Cell, 9(8):693–716, September 2017. URL: http://dx.doi.org/10.1007/s13238-017-0469-4, doi:10.1007/s13238-017-0469-4. This article has 27 citations.](https://doi.org/10.1007/s13238-017-0469-4)

[5. (Aslan2023Trak) Merve Aslan, Andrew M. Hensley, John Canty, Amanda Jack, and Ahmet Yildiz. Trak adaptors regulate the recruitment and activation of dynein and kinesin in mitochondrial transport. Biophysical Journal, 122(3):25a–26a, February 2023. URL: http://dx.doi.org/10.1016/j.bpj.2022.11.360, doi:10.1016/j.bpj.2022.11.360. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bpj.2022.11.360)

6. (Canty2021TRAK) TRAK adaptors coordinate the recruitment and activation of dynein and kinesin to control mitochondrial transport. This article has 21 citations.

7. (Gladkova2024A) A molecular switch for stress-induced activation of retrograde mitochondrial transport. This article has 0 citations.

[8. (Onodera2018Arf6driven) Yasuhito Onodera, Jin-Min Nam, Mei Horikawa, Hiroki Shirato, and Hisataka Sabe. Arf6-driven cell invasion is intrinsically linked to trak1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe. Nature Communications, July 2018. URL: http://dx.doi.org/10.1038/s41467-018-05087-7, doi:10.1038/s41467-018-05087-7. This article has 65 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-05087-7)

[9. (Li2024Role) Ren-Ke Li, Yu-Rong Xiong, Shu-Jing Pan, Wen-Ting Lei, Xiao-Mei Shu, Xiao-Qi Shi, and Mao-Qiang Tian. Role of trak1 variants in epilepsy: genotype–phenotype analysis in a pediatric case of epilepsy with developmental disorder. Frontiers in Molecular Neuroscience, February 2024. URL: http://dx.doi.org/10.3389/fnmol.2024.1342371, doi:10.3389/fnmol.2024.1342371. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2024.1342371)

[10. (van2013TRAKMilton) Myrrhe van Spronsen, Marina Mikhaylova, Joanna Lipka, Max A. Schlager, Dave J. van den Heuvel, Marijn Kuijpers, Phebe S. Wulf, Nanda Keijzer, Jeroen Demmers, Lukas C. Kapitein, Dick Jaarsma, Hans C. Gerritsen, Anna Akhmanova, and Casper C. Hoogenraad. Trak/milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron, 77(3):485–502, February 2013. URL: http://dx.doi.org/10.1016/j.neuron.2012.11.027, doi:10.1016/j.neuron.2012.11.027. This article has 345 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2012.11.027)